U.S. Stock News

NYSE:PKG
NYSE:PKGPackaging

A Look At Packaging Corp Of America (PKG) Valuation After Earnings Miss And Mixed Analyst Reactions

Packaging Corporation of America (PKG) is back in focus after missing fourth quarter earnings expectations, as mixed analyst reactions and talk of potential March price hikes intersect with questions about margins, volumes, and capital efficiency. See our latest analysis for Packaging Corporation of America. The recent earnings miss and talk of March price hikes come on the back of a strong run, with a 30 day share price return of 12.58% and a 1 year total shareholder return of 22.49%...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

Trupanion (TRUP) Valuation Check As Earnings Focus Turns To Slower Revenue Growth Expectations

Trupanion (TRUP) is back in focus ahead of its earnings report after Thursday’s close, with investors weighing slower forecast revenue growth against the company’s record of topping Wall Street expectations. See our latest analysis for Trupanion. At a share price of US$32.33, Trupanion’s short term momentum has softened, with a 30 day share price return of 11.69% and a year to date share price return decline of 13.09%, adding to a 12 month total shareholder return decline of 30.22%, even as...
NasdaqGS:OSBC
NasdaqGS:OSBCBanks

Old Second Bancorp Buyback Signals Confidence In Undervalued Shares

Old Second Bancorp (NasdaqGS:OSBC) has authorized a new share repurchase program of up to $43.9 million. The buyback authorization extends through 2026. The program adds another capital return tool alongside existing balance sheet and lending activities. Old Second Bancorp, the holding company for Old Second National Bank, operates as a regional banking provider focused on lending, deposits, and other financial services. For investors, a new repurchase authorization of this size can be an...
NYSE:YOU
NYSE:YOUSoftware

Is It Time To Reassess Clear Secure (YOU) After Its Mixed Share Price Performance

If you are trying to figure out whether Clear Secure is attractively priced or already reflecting the story in its share price, you are in the right place. The stock recently closed at US$32.54, with a 2.4% gain over the last 7 days, a 7.0% decline over 30 days, a 5.4% decline year to date, and a 38.2% return over 1 year, while the 3 year return sits at 18.3%. These mixed short term moves alongside stronger 1 year performance have kept Clear Secure on many investors' watchlists, especially...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

A Look At Stoke Therapeutics (STOK) Valuation After Strong One Year Share Price Momentum

Recent performance snapshot Stoke Therapeutics (STOK) has drawn fresh attention after recent share price moves, with the stock showing a 1 day return of about a 1% decline, alongside modest gains over the past week. Investors are also weighing its roughly 10% return over the past month and about 24% over the past 3 months, compared with longer term figures and the company’s early stage biopharmaceutical profile. See our latest analysis for Stoke Therapeutics. Looking beyond the recent moves,...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Assessing American Superconductor (AMSC) Valuation After Earnings Beat And Upgraded Guidance

American Superconductor (AMSC) is back in focus after reporting Q3 results that exceeded expectations, highlighting higher sales, sharply stronger net income, and management commentary pointing to momentum across energy, data center, and military markets. See our latest analysis for American Superconductor. The latest results and guidance arrived after a strong run in the share price, with a 24.09% 7 day share price return and a 12.88% 1 year total shareholder return, suggesting momentum has...
NYSE:CNR
NYSE:CNROil and Gas

Dividend, Buybacks and Losses Could Be A Game Changer For Core Natural Resources (CNR)

Core Natural Resources, Inc. has reported its fourth-quarter 2025 results, with sales rising to US$1,042.47 million while posting a net loss of US$78.98 million, and the board has declared a US$0.10 per share quarterly dividend payable on March 16, 2026, to shareholders of record on March 2, 2026. The company also completed a share repurchase program totaling 3,088,520 shares for US$224.29 million and issued 2026 sales volume guidance of 85.6 million to 91.4 million tons, offering fresh...
NYSE:DE
NYSE:DEMachinery

Assessing Deere’s (DE) Valuation After Strong Recent Share Price Momentum

Why Deere is on investors’ radar today Without a single headline event setting things off, Deere (DE) is drawing attention after a strong run in its share price and solid recent financial metrics that have many investors reassessing the stock. See our latest analysis for Deere. The recent move in Deere’s share price, now at US$612.69 after a 24.85% 1 month share price return and 31.25% year to date share price return, sits alongside a 5 year total shareholder return of 109.56%. This suggests...
NYSE:NUE
NYSE:NUEMetals and Mining

Is Nucor (NUE) Still Attractive After Strong 1-Year Share Price Performance?

If you are wondering whether Nucor’s current share price fairly reflects its underlying worth, you are not alone. This article is designed to help you assess that. Nucor’s stock closed at US$194.42, with returns of 2.4% over 7 days, 17.1% over 30 days, 14.8% year to date, 48.0% over 1 year and 19.4% over 3 years. These moves naturally raise questions about how the valuation stacks up. Recent attention on Nucor has focused on its role in the US materials sector and how investors are thinking...
NYSE:KBR
NYSE:KBRProfessional Services

Is KBR (KBR) Pricing Reflect Its DCF And Earnings-Based Valuation Estimates Today

If you are wondering whether KBR's current share price lines up with its underlying worth, you are not alone and this article is here to help you size up that question quickly. KBR closed at US$40.90, with returns of 4.1% decline over 7 days, 7.7% decline over 30 days, a 1.0% gain year to date, and a 22.2% decline over 1 year, while the 5 year return sits at 36.7% and the 3 year return at 18.4% decline. Recent coverage around KBR has focused on its position in the commercial services space...
NYSE:KVYO
NYSE:KVYOSoftware

Klaviyo (KVYO) Turns Q4 Profit As EPS Beat Tests Profitability Skeptics

Klaviyo (KVYO) has capped FY 2025 with Q4 revenue of US$350.2 million and basic EPS of US$0.02, while on a trailing twelve month basis the business generated US$1.2 billion of revenue and a net loss of US$31.8 million. The company has seen quarterly revenue move from US$270.2 million in Q4 FY 2024 to US$350.2 million in Q4 FY 2025, and basic EPS shift from a loss of US$0.10 to a small profit of US$0.02 over the same period. This sets up an earnings season story that hinges on how durable this...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Is It Time To Reassess First Merchants (FRME) After Recent Share Price Stability?

If you are looking at First Merchants and wondering whether the current share price still represents good value, you are not alone. The stock last closed at US$42.05, with returns of 0.5% over the past 7 days, 11.7% over 30 days, 12.1% year to date and a 1% decline over the past year, which may signal changing expectations around its prospects and risk. This article was prompted by Simply Wall St's evergreen coverage of First Merchants, which periodically refreshes to keep valuation and...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Is It Too Late To Consider Tradeweb Markets (TW) After Recent Electronic Trading Headlines?

If you are wondering whether Tradeweb Markets is pricing in too much optimism or not enough, the next sections will walk through what the current share price might be implying about the business. The stock recently closed at US$115.02, with returns of 14.1% over the last 7 days, 9.6% over the last 30 days, 8.3% year to date, 53.8% over 3 years and 73.0% over 5 years. The 1 year return sits at a 9.0% decline. Recent news coverage around Tradeweb Markets has focused on its role as an...
NYSE:ALLE
NYSE:ALLEBuilding

Does Allegion’s 12th Dividend Hike Reveal a Deeper Capital Allocation Shift for ALLE?

Allegion plc recently declared a quarterly dividend of US$0.55 per ordinary share, an 8% increase from 2025 and its 12th consecutive annual dividend raise, payable on March 31, 2026 to shareholders of record on March 13, 2026. This extended streak of rising dividends highlights Allegion’s ongoing focus on returning cash to shareholders while signaling confidence in its ability to sustain such payouts. With Allegion’s 8% dividend increase underscoring its emphasis on shareholder returns,...
NYSE:MNTN
NYSE:MNTNMedia

MNTN (MNTN) Turns First Quarterly Profit And Tests Bullish Narratives

MNTN (MNTN) has put a cleaner set of numbers on the table for FY 2025 so far, with Q3 revenue of US$70.0 million and basic EPS of US$0.09 off net income of US$6.4 million, against a trailing twelve month backdrop that still shows a loss of US$44.9 million on revenue of US$272.8 million and EPS of US$1.25. The company has seen quarterly revenue move from US$54.8 million in Q2 2024 to US$70.0 million in Q3 2025. EPS has swung across losses of US$0.69, US$1.41 and US$0.65 in early FY 2025 before...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Margin Compression To 17.5% Tests Premium P/E Narrative

Edwards Lifesciences FY 2025 earnings snapshot Edwards Lifesciences (EW) has wrapped up FY 2025 with fourth quarter revenue of US$1,569.6 million and basic EPS of US$0.11, setting the tone for how investors assess the latest stretch of results. The company has seen revenue move from US$1,385.8 million in Q4 2024 to US$1,569.6 million in Q4 2025, while basic EPS over that same period went from US$0.59 to US$0.11. This puts the focus squarely on how efficiently those sales are translating into...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology

Quest Diagnostics (NYSE:DGX) has introduced a blood based minimal residual disease test for multiple myeloma that uses advanced flow cytometry. The company reports that the assay offers sensitivity comparable to next generation sequencing with a lower expected cost and less invasive sampling. FDA draft guidance recognizes minimal residual disease as an endpoint in multiple myeloma clinical trials, supporting broader use of MRD testing in research. For you as an investor, this development...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

A Look At Construction Partners (ROAD) Valuation After Strong Q1 Results And Upgraded Outlook

Construction Partners (ROAD) has just combined a strong quarterly update with a raised full year outlook, after reporting higher first quarter sales and a move from loss to profit compared with a year earlier. See our latest analysis for Construction Partners. The strong quarterly beat and upgraded guidance have coincided with a sharp pick up in momentum, with a 1 month share price return of 14.62% and a 1 year total shareholder return of 66.51% building on a very large 5 year total...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab’s First Profitable Year Resets Capital Returns And Growth Plans

Grab Holdings (NasdaqGS:GRAB) reports its first full year of net profit. The company launches a $500 million share buyback program. Grab announces the acquisition of Stash Financial to expand into wealth services. Grab partners with Hesai Technology to distribute lidar products across Southeast Asia. Grab Holdings is moving through a major shift, pairing its first full year of net profit with several new capital and business moves. The share price sits at $4.23, with a 3 year return of...